These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13873272)

  • 21. A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in treatment of the acute leukemias of childhood: results of a coperative study.
    SULLIVAN MP; BEATTY EC; HYMAN CB; MURPHY ML; PIERCE MI; SEVERO NC
    Cancer Chemother Rep; 1962 May; 18():83-95. PubMed ID: 13918321
    [No Abstract]   [Full Text] [Related]  

  • 22. THE EFFECT OF ANTIMETABOLITES ON THE RESPIRATION OF LEUKEMIC MOUSE CELLS.
    WOODLIFF HJ
    Blood; 1963 Aug; 22():199-208. PubMed ID: 14045303
    [No Abstract]   [Full Text] [Related]  

  • 23. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ; Otter GM; Stock CC
    Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: allopurinol co-therapy is safe and effective in autoimmune hepatitis.
    Al-Shamma S; McCrudden R; McLaughlin S
    Aliment Pharmacol Ther; 2013 May; 37(9):919. PubMed ID: 23551160
    [No Abstract]   [Full Text] [Related]  

  • 25. The effectiveness of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio] purine against transplantable mouse leukemia.
    VENDITTI JM; FREI E; GOLDIN A
    Cancer Chemother Rep; 1960 Jul; 8():44-6. PubMed ID: 13855208
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio]purine (imidazolylthioguanine; B.W. 57-323) on acute leukemia in man.
    SELAWRY OS
    Cancer Chemother Rep; 1960 Jul; 8():56-60. PubMed ID: 13854751
    [No Abstract]   [Full Text] [Related]  

  • 27. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
    JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: allopurinol co-therapy is safe and effective in autoimmune hepatitis -- authors' reply.
    de Boer YS; van Gerven NM; de Boer NK; Mulder CJ; Bouma G; van Nieuwkerk CM
    Aliment Pharmacol Ther; 2013 May; 37(9):920. PubMed ID: 23551161
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination chemotherapy in acute leukemia in childhood: corticosteroids, 6-mercaptopurine, and folic acid antagonists.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1961 Dec; 133():422-30. PubMed ID: 14496653
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.
    Erb N; Harms DO; Janka-Schaub G
    Cancer Chemother Pharmacol; 1998; 42(4):266-72. PubMed ID: 9744770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of 6-mercaptopurine riboside in 55 cases of childhood leukemia].
    Ise T; Aoki T; Akatsuka J; Ueda Y; Koide R
    Rinsho Ketsueki; 1973 Jan; 14(1):67-71. PubMed ID: 4511335
    [No Abstract]   [Full Text] [Related]  

  • 32. [AZAURACIL RIBOSIDE AND AZAURACIL RIBOSIDE TRIACETATE IN THE THERAPY OF LEUKEMIA IN CHILDREN].
    MISAROVA Z; ELIS J
    Cesk Pediatr; 1964 Feb; 19():161-5. PubMed ID: 14142689
    [No Abstract]   [Full Text] [Related]  

  • 33. The frequency of the various morphologic types of childhood leukemia and their response to certain chemotherapeutic agents.
    CARTER RE; BRUBAKER CA; LEIKIN SL; LOUIS J; SEVERO N; WOLFF JA
    Cancer Chemother Rep; 1962 Feb; 16():155-6. PubMed ID: 13876967
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of children with acute leukosis according to current trends].
    KISLIAK NS; MAKHONOVA LA
    Pediatriia; 1962 Oct; 40():80-5. PubMed ID: 14033088
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.
    BURCHENAL JH; MURPHY ML; ELLISON RR; SYKES MP; TAN TC; LEONE LA; KARNOFSKY DA; CRAVER LF; DARGEON HW; RHOADS CP
    Blood; 1953 Nov; 8(11):965-99. PubMed ID: 13105700
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative evaluation of ACTH and hydrocortisone used alone and in sequence with 6-mercaptopurine in the treatment of acute leukemia in children -- preliminary report of a cooperative study.
    SUTOW WW
    Cancer Chemother Rep; 1962 Feb; 16():157-9. PubMed ID: 13918541
    [No Abstract]   [Full Text] [Related]  

  • 37. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
    Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
    Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
    Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental, clinical, and metabolic studies of thiopurines.
    ELION EB; CALLAHAN SW; HITCHINGS GH; RUNDLES RW; LASZLO J
    Cancer Chemother Rep; 1962 Feb; 16():197-202. PubMed ID: 13889847
    [No Abstract]   [Full Text] [Related]  

  • 40. SUMMARY OF INFORMAL DISCUSSION ON THE ROLE OF PURINE ANTAGONISTS.
    HITCHINGS GH
    Cancer Res; 1963 Sep; 23():1218-25. PubMed ID: 14070378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.